Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
about
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesisPhosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cellsReplacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responsesThe Role of Gastrin and CCK Receptors in Pancreatic Cancer and other MalignanciesThe utility of transposon mutagenesis for cancer studies in the era of genome editing.Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistanceRASopathies: unraveling mechanisms with animal modelsThe atypical PKCs in inflammation: NF-κB and beyondPreclinical Murine Models for Lung Cancer: Clinical Trial ApplicationsAnimal models of colorectal cancerStrategies to achieve conditional gene mutation in miceEffect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeOncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancerOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisRAS oncogenes: weaving a tumorigenic webGermline KRAS mutations cause Noonan syndromeActivated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysLoss of the tumor suppressor Pten promotes proliferation of Drosophila melanogaster cells in vitro and gives rise to continuous cell linesThe intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathwayBRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsMenin determines K-RAS proliferative outputs in endocrine cellsOncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosisRole of cleavage by separase of the Rec8 kleisin subunit of cohesin during mammalian meiosis I.Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumorsA DNA transposon-based approach to validate oncogenic mutations in the mouseRas oncogenes: split personalitiesNovel KRAS gene mutations in sporadic colorectal cancerRas history: The saga continues.Perturbing the cellular levels of steroid receptor coactivator-2 impairs murine endometrial function.Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cellsConditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseRas effector switching promotes divergent cell fates in C. elegans vulval patterning.Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cellsImage-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.Frs2α and Shp2 signal independently of Gab to mediate FGF signaling in lens development.Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancerMinireview: physiological and pathological actions of RAS in the ovary.
P2860
Q24316409-032C48AD-287D-4D53-BFB7-EEC5C0D5BF44Q24318292-DBAFBC79-0DE2-483D-BBCC-E74753B0147BQ24658420-D94DCFA5-6D81-49DF-ACB7-A151695795E3Q26765244-2D533557-92BB-41D7-9672-AF5AF95CB626Q26781762-95A4EABC-9AEA-45A7-8B04-3FCC705E4451Q26795609-B9EB9992-EBE2-4938-B01A-2041B68538A7Q26800379-10466F76-A625-4B53-BEDA-4A08C9B3973EQ26829823-64DB3954-73A3-4873-9410-18C30B7591F5Q26863474-550E20B1-75B7-4B67-A83F-5DABB64FAC5FQ27009170-F002999B-9649-424D-B155-BBC9F314385AQ27023444-E0F4E48B-508A-45F6-B6E9-0E691CAD2B1EQ27851703-A0B2F7D7-C74E-4B49-A2DA-60FB486AB425Q28077545-776F3DA6-172F-47E5-8FD8-DA3549848DEEQ28242612-58D2F234-D79A-4A7C-9152-373F489C7268Q28250360-7CB3A998-87B9-4310-ABE9-9D15E366D47BQ28297024-E3F45A05-97AE-46C0-AF58-AB48E58A160EQ28478427-BAF8F990-707B-4D44-9F34-EA82EF98E005Q28480990-34E6AC16-51FF-4C12-8A84-75A85246E8A1Q28512744-5AA58D99-25D0-4FA3-99B4-193BE1FFB898Q28543370-2ACB11C8-134B-4EB9-9D9C-F214C22B7455Q28589291-0424CF8F-1355-480D-90C5-00D98DF26F59Q28589373-FD85C8A5-30EA-4582-8070-067239B92588Q28593432-1F1D8256-7C8D-4787-B389-5B9D036F138FQ28729079-CABA4EBA-7344-47AF-954A-7909AC6A0748Q28756297-85D97DEF-2BD4-430B-AC95-E3A0B4513A97Q29615405-C660FE2C-6CBE-43ED-A4CC-1D3A49F2457CQ30368810-67917B1E-BDA8-4B90-866A-EBE19859C9DAQ30404024-05FBA3CB-3BBF-4F29-9A8E-3AF196B6439AQ30412564-3A550155-4DF6-4426-9644-0F445134159BQ30435060-6E6ECD60-B86B-48B7-A3E6-DE1271FF97F6Q30490786-E4816A08-2C61-48B3-ADE5-A0957C3343E1Q30498007-38DBC4C1-DBF0-478B-908E-51BEE6962720Q30531111-5182FFE8-E70E-4F7A-9786-2D1ABFE4C88DQ30803684-6E7B7D17-6F58-4D00-AD4F-B0845E349783Q33377270-11C8717C-EC1B-4B5B-A411-66CA04158759Q33486497-084BD209-7567-443D-AAAE-02B7A1304EB0Q33551923-30B11DC0-1C01-41F5-B1DA-2431FAACF022Q33557690-04079C31-D3C2-4566-87BD-D1648F037476Q33591673-CAE999E2-4468-46F0-B907-57D43E5FB607Q33634251-1BD56B2B-9670-4932-8D40-7A4ACEC59882
P2860
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Endogenous oncogenic K-ras
@nl
Endogenous oncogenic K-ras(G12 ...... tic and developmental defects.
@en
type
label
Endogenous oncogenic K-ras
@nl
Endogenous oncogenic K-ras(G12 ...... tic and developmental defects.
@en
prefLabel
Endogenous oncogenic K-ras
@nl
Endogenous oncogenic K-ras(G12 ...... tic and developmental defects.
@en
P2093
P1433
P1476
Endogenous oncogenic K-ras(G12 ...... stic and developmental defects
@en
P2093
Alice T Shaw
Catrina King
Daniel P Silver
Denise Crowley
Erica L Jackson
Hanno Hock
Kim L Mercer
Michael A Jacobetz
Nicholas A Willis
P304
P356
10.1016/S1535-6108(04)00085-6
P577
2004-04-01T00:00:00Z